Zenicor Medical Systems AB
The answer first
Does Zenicor Medical Systems beat the market?
No, Zenicor Medical Systems has not beaten the market over the last year.
Max for seven days
Follow Zenicor Medical Systems with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Zenicor Medical Systems
Your first answer is free, no account needed.
Do you own Zenicor Medical Systems, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Zenicor Medical Systems and a few more. Free, no card.
Super Stock+46.4%In short
- Zenicor Medical Systems has fallen 48.5% over the past year, including dividends.
- The largest fall over the past three years was 95.4%. The price is 98.5% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
- Debt to equityBorrowings divided by equity0.11
- Asset turnoverSales divided by everything the company owns0.37
- Return on equityProfit divided by equity+1.8%
- Cash conversionOperating cash flow divided by profit−8.87
The ranking is built on equity ratio, ROA and how steadily profit grows.
- P/BPrice divided by equity0.3
- P/SPrice divided by sales0.6
- P/EPrice divided by earnings16.4
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
- 3 months−35.0%
- 6 months−43.7%
- 9 months−38.0%
- 12 months−48.5%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Zenicor Medical Systems
Zenicor Medical Systems AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Zenicor Medical Systems is number 119 of 137 companies in healthcare on Nasdaq Stockholm. Zenicor Medical Systems has not paid a dividend in the past twelve months. The share trades in SEK. It has around 20 employees.
Zenicor Medical Systems AB (publ), a medical technology company, develops systems and care chains for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provides Zenicor Direct, a solution with interpretation services and services for device logistics; and DeepRhythmAI, an AI technology of Zenicor Solution for modern arrhythmia diagnostics. The company was incorporated in 2003 and is headquartered in Stockholm, Sweden.


See the full analysis of Zenicor Medical Systems.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card